Bell Rock Capital LLC Amgen Inc Transaction History

Bell Rock Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $500 - $586	-3 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$178.4 - $208.25 $8,384 - $9,787	-47 Reduced 94.0%	3 $0
Q1 2018 Nov 14, 2018	SELL	$169.43 - $198.0 $8,471 - $9,900	-50 Reduced 50.0%	50 $9,000
Q4 2017 Nov 13, 2018	SELL	$168.79 - $188.59 $6,751 - $7,543	-40 Reduced 28.57%	100 $17,000
Q2 2017 Dec 06, 2018	BUY	N/A	140	140 $24,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.